President-elect Donald Trump’s plan to impose tariffs on imported goods is expected to affect the prices of approximately 75% of medical devices marketed in the U.S., according to consulting firm GlobalData’s Medsource Database, Medical Device Network …
The FDA’s Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
Medical device recalls, whether voluntary or mandated, are crucial for ensuring patient safety.
Baxter announced the release of its first 1-liter IV solutions manufactured post-hurricane, marking a significant step in addressing the ongoing IV shortage.
The U.S. supply chain is preparing itself for two major potential shifts in early 2025, bracing for new Trump-era tariffs partnered with the possibility of a port strike that could begin in mid-January.
The American Medical Manufacturers Association is calling on Congress to quickly reauthorize the Pandemic and All-Hazards Preparedness Act before the end of the 118th Congressional Session in January 2025.
Medtronic reported its second-quarter financial results for the fiscal year 2025, showing a 5.3% increase in total revenue, reaching $8.4 billion.
As the medical device industry looks ahead to potential policies under the new administration, key decisions could shape the future of innovation, regulation and reimbursement in this sector.
Dr. Shirin Towfigh, MD, a Beverly Hills surgeon with over two decades of experience, is suing Medtronic, accusing the global medical device giant of stealing her patented hernia mesh design, CNBC reported Nov. 13.
Gartner has released its 16th annual Gartner Healthcare Supply Chain Top 25 ranking recognizing U.S. health systems that demonstrate leadership in supply chain.
